INTRODUCTION: Anemia is an inevitable outcome of chronic renal failure due to the kidney's decreased ability to produce erythropoietin (EPO). We examined the feasibility of isolating and expanding EPO-producing cells for cell-based therapy. MATERIALS AND METHODS: Renal cells from 7- to 10-day-old mice were culture-expanded. The cells at each subculture stage were characterized for EPO expression, using immunocytochemistry, FACS, and Western Blot analysis, with EPO-specific antibodies. To assess the levels of EPO expression, cells incubated under normoxic and hypoxic conditions were analyzed. RESULTS: Immunocytochemical analysis of the cultured renal cells expressed EPO at each subculture stage (P1-P3). Western Blot analysis of the detergent-solubilized cell extracts detected EPO (34 kDa) protein in the kidney cells of all passages tested. CONCLUSION: These results demonstrate that EPO-producing renal cells can be grown and expanded in culture. The cells stably expressed EPO at multiple subculture stages and they are able to form tissue in vivo. This study shows that EPO-producing cells may be used as a potential treatment option for anemia caused by chronic renal failure.
INTRODUCTION:Anemia is an inevitable outcome of chronic renal failure due to the kidney's decreased ability to produce erythropoietin (EPO). We examined the feasibility of isolating and expanding EPO-producing cells for cell-based therapy. MATERIALS AND METHODS: Renal cells from 7- to 10-day-old mice were culture-expanded. The cells at each subculture stage were characterized for EPO expression, using immunocytochemistry, FACS, and Western Blot analysis, with EPO-specific antibodies. To assess the levels of EPO expression, cells incubated under normoxic and hypoxic conditions were analyzed. RESULTS: Immunocytochemical analysis of the cultured renal cells expressed EPO at each subculture stage (P1-P3). Western Blot analysis of the detergent-solubilized cell extracts detected EPO (34 kDa) protein in the kidney cells of all passages tested. CONCLUSION: These results demonstrate that EPO-producing renal cells can be grown and expanded in culture. The cells stably expressed EPO at multiple subculture stages and they are able to form tissue in vivo. This study shows that EPO-producing cells may be used as a potential treatment option for anemia caused by chronic renal failure.
Authors: F K Lin; S Suggs; C H Lin; J K Browne; R Smalling; J C Egrie; K K Chen; G M Fox; F Martin; Z Stabinsky Journal: Proc Natl Acad Sci U S A Date: 1985-11 Impact factor: 11.205
Authors: Chase A Arbra; Satish N Nadig; Sarah Grace Dennis; Sanket Pattanaik; Heather A Bainbridge; J Matthew Rhett; Stephen A Fann; Carl Atkinson; Michael J Yost Journal: J Vis Exp Date: 2018-03-27 Impact factor: 1.355
Authors: Liliya M Yamaleyeva; Nadia K Guimaraes-Souza; Louis S Krane; Sigrid Agcaoili; Kenneth Gyabaah; Anthony Atala; Tamer Aboushwareb; James J Yoo Journal: Stem Cells Transl Med Date: 2012-05-03 Impact factor: 6.940
Authors: Joydeep Basu; Christopher W Genheimer; Namrata Sangha; Sarah F Quinlan; Kelly I Guthrie; Rusty Kelley; Roger M Ilagan; Deepak Jain; Timothy Bertram; John W Ludlow Journal: Lipids Health Dis Date: 2011-09-29 Impact factor: 3.876
Authors: Sunil K George; Mehran Abolbashari; John D Jackson; Tamer Aboushwareb; Anthony Atala; James J Yoo Journal: PLoS One Date: 2016-10-24 Impact factor: 3.240
Authors: Sophie L Dahl; Andreas M Bapst; Stellor Nlandu Khodo; Carsten C Scholz; Roland H Wenger Journal: Pflugers Arch Date: 2022-06-24 Impact factor: 4.458